Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE RECOMMENDATIONS IN AUSTRALIA

Simple item page
dc.contributor.authorTurkstra, Erika
dc.contributor.authorBettington, Emilie
dc.contributor.authorDonohue, Maria L
dc.contributor.authorMervin, Merehau C
dc.date.accessioned2022-05-19T00:55:38Z
dc.date.issued2017
dc.date.updated2020-12-27T07:33:30Z
dc.description.abstractObjectives: The aim of this study was to examine submissions made to the Pharmaceutical Benefits Advisory Committee (PBAC) and assess whether the predicted financial impact was associated with a recommendation. The second objective was to assess whether the financial and utilization estimates for listing the proposed medicine were reliableen_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0266-4623en_AU
dc.identifier.urihttp://hdl.handle.net/1885/265568
dc.language.isoen_AUen_AU
dc.publisherCambridge University Pressen_AU
dc.rights© 2017 The authorsen_AU
dc.sourceInternational Journal of Technology Assessment in Health Careen_AU
dc.subjectReimbursementen_AU
dc.subjectHealth budgeten_AU
dc.subjectResource allocationen_AU
dc.subjectPharmaceutical Benefits Advisory Committeeen_AU
dc.subjectBudget impact analysisen_AU
dc.titlePHARMACEUTICAL BENEFITS ADVISORY COMMITTEE RECOMMENDATIONS IN AUSTRALIAen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue4en_AU
local.bibliographicCitation.lastpage528en_AU
local.bibliographicCitation.startpage521en_AU
local.contributor.affiliationTurkstra, Erika, College of Asia and the Pacific, ANUen_AU
local.contributor.affiliationBettington, Emilie, Griffith Universityen_AU
local.contributor.affiliationDonohue, Maria L, Griffith Universityen_AU
local.contributor.affiliationMervin, Merehau C, Griffith Universityen_AU
local.contributor.authoruidTurkstra, Erika, u1032022en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor111700 - PUBLIC HEALTH AND HEALTH SERVICESen_AU
local.identifier.absfor140200 - APPLIED ECONOMICSen_AU
local.identifier.ariespublicationu4485658xPUB823en_AU
local.identifier.citationvolume33en_AU
local.identifier.doi10.1017/S0266462317000617en_AU
local.identifier.scopusID2-s2.0-85023758938
local.identifier.thomsonID000418324200017
local.publisher.urlhttps://www.cambridge.org/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Turkstra_PHARMACEUTICAL_BENEFITS_2017.pdf
Size:
204.8 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS